Clinical Evaluation of Hyaluronic Acid and Platelet Rich Fibrin Injection Efficacy in Interdental Papilla Reconstruction

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

13 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-10

Study Completion Date

2025-06-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to evaluate and compare the efficacy of injectable platelet rich fibrin (i-PRF) and hyaluronic acid (HA) in reconstruction of interdental papilla loss. The main questions it aims to answer are:

* How compareable are above mentioned two interventions (i-PRF\&HA) in reconstruction of interdental papilla loss?
* Which treatment option is better accepted by patients? Which treatment option would patients be more satisfied with? Participants with multiple interdental papilla loss will be treated with both i-PRF and HA in split-mouth design. Researchers will compare two treatment options to see if black triangles caused by interdental papilla loss closes and if yes, for how long do they last.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparing Microneedling and Injectable Platelet Rich Fibrin to Hyaluronic Acid In Papilla Reconstruction

NCT07280507

Papilla Reconstruction

ACTIVE_NOT_RECRUITING EARLY_PHASE1

Clinical Evaluation of Photobiomodulated Hyaluronic Acid Therapy for Interdental Papillary Loss: Minimal Invasive Blind Split Mouth Technique

NCT07012525

Interdental Papillae Reconstruction

NOT_YET_RECRUITING PHASE1/PHASE2

Efficacy of HA Gel Injection Versus Multilayer (L-PRF) in the Interdental Papilla Reconstruction

NCT05953896

Gingival Papillary Cratering

COMPLETED NA

Comparison of the Efficacy of Platelet-rich Fibrin and Connective Tissue Graft in Interdental Papilla Reconstruction

NCT05207696

To Evaluate the Efficacy of Platelet-rich Fibrin in Papilla Reconstruction To Evaluate the Efficacy of Connective Tissue Graft in Papilla Reconstruction

COMPLETED

Platelet Rich Fibrin in the Treatment of Localized Gingival Recessions

NCT01793389

Gingival Recession

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Nowadays, individuals give great importance to their appearance and dental aesthetics plays a key role in their personal appearance. Dental aesthetics is a combination of white and pink aesthetics formed by teeth and gums. The part of the gingival tissue that fills the triangular shaped spaces between the teeth is the interdental papilla. The presence of papillae in the teeth is closely related to the distance between the contact point between the teeth and the alveolar bone crest. Periodontal diseases, traumatic oral hygiene practices, incorrect orthodontic forces, incompatible restoration contour, the presence of diastema as a result of neighbouring teeth not being in contact, and tooth loss can cause loss of interdental papillae, resulting in the formation of gaps called black triangles. In addition to aesthetic problems, loss of interdental papillae can cause speech difficulties and food impaction.

Interdental papilla loss is one of the most important aesthetic periodontal difficulties and at the same time one of the most difficult problems to treat. Various surgical methods and flap designs have been proposed for the treatment and reconstruction of interdental papillae. However, current surgical methods have limited success and lack predictability, especially because the gingival papilla has a sensitive structure and less blood supply compared to other parts of the gingiva. Therefore, non-surgical methods have gained importance. As a result of the development of tissue engineering, dermal filling materials have started to be produced in recent years. Among these materials, hyaluronic acid (HA) is one of the basic components of connective tissue and especially its water binding/retention property makes it a determinant of tissue volume. HA enables the migration of fibroblast cells involved in collagen production and also acts as a liquid matrix where collagen and elastic fibres will proliferate. Due to these properties, Becker et al. first demonstrated in 2010 that it was possible to reconstruct a small area of interdental papilla loss in a minimally invasive and predictable manner using injectable HA gel. Subsequently, HA injections in interdental papil reconstructions have frequently been successfully reported in the literature.

Platelet Rich Fibrin (PRF) is an autologous, membrane-form product prepared by centrifugation of the patient's own blood. This fibrin matrix containing platelets, leukocytes and various growth factors is used especially in regenerative periodontal surgical operations. Injectable PRF (i-PRF), obtained by modifying the preparation protocol, forms a dynamic hydrogel by increasing the number of cells and releasing growth factors more frequently. I-PRF serves as a source of slow-release growth factors that help remodelling of the interdental papilla. Using data obtained through standardised photographs, the project will evaluate the effectiveness of area closure rates of black triangles caused by papilla loss over a 3-month period and measure patient feedback and satisfaction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Interdental Papilla Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

A type of study used frequently in oral research: the mouth is divided into two or more subunits. Active and control (comparison) treatments are applied to the subunits (e.g., to the left and right sides).

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Participant will be masked, which side of her/his mouth will be treated with either i-PRF or HA. The outcome assessor is blinded to the treatment modalities.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Injectable PRF

i-PRF is produced by cenrifugation of patients own blood. Injection of 0.1-0.2 ml per interdental papilla 3 times with 3-week interval.

Group Type ACTIVE_COMPARATOR

I-PRF Injection

Intervention Type BIOLOGICAL

İnterdental papilla will be injected by i-PRF.

Teosyal PureSense Global Action HA Injection

Intervention Type DRUG

Interdental papilla will be injected by Teosyal PureSense Global Action HA gel.

Hyaluronic Acid

Teosyal® Global Action PureSense. Composition: Cross-linked hyaluronic acid (HA): 25 mg/ml Lidocaine; 0,3%, (injection).

Injection of 0.1-0.2 ml per interdental papilla 3 times with 3-week interval.

Group Type ACTIVE_COMPARATOR

I-PRF Injection

Intervention Type BIOLOGICAL

İnterdental papilla will be injected by i-PRF.

Teosyal PureSense Global Action HA Injection

Intervention Type DRUG

Interdental papilla will be injected by Teosyal PureSense Global Action HA gel.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

I-PRF Injection

İnterdental papilla will be injected by i-PRF.

Intervention Type BIOLOGICAL

Teosyal PureSense Global Action HA Injection

Interdental papilla will be injected by Teosyal PureSense Global Action HA gel.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Systemically healthy (without cardiovascular diseases, diabetes, thyroid diseases, auto-immune diseases)
* Patients with PPI 2 and PPI 3 papillae according to the Papillary Presence Index classification
* Probable pocket depth of 4 mm or less in the relevant area
* Plaque index and gingival index in the range of 0-1
* Neighbouring teeth in contact with each other in the relevant area
* Absence of any restoration in the relevant area
* Non-smoker
* No surgical periodontal treatment in the last 6 months
* For female subjects not pregnant or lactating
* No known allergy to hyaluronic acid

Exclusion Criteria

* Not systemically healthy (with cardiovascular diseases, diabetes, thyroid diseases, auto-immune diseases)
* Diagnosed with periodontitis
* History of allergic reactions to hyaluronic acid
* Less than 2 mm keratinized tissue height in the relevant area
* Teeth crowding in relevant area
* Any kind of restoration (fillings, crowns, etc.) in the relevant area
* Smoker
* Ongoing orthodontic treatment
* Having parafunctional habits (bruxism, etc.)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes